EPAS1 and renal cell carcinoma: HIF-1α and HIF-2α drive metabolic reprogramming in RCC cells, which is characterized by enhanced glycolysis and reduced glucose oxidation, a compensatory increase in consumption of glutamine, increased flux of glutamine-derived carbons into the TCA cycle [11], and a reliance on glutamine for growth and proliferation [12–14].